1. Home
  2. GMRE vs MRVI Comparison

GMRE vs MRVI Comparison

Compare GMRE & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMRE
  • MRVI
  • Stock Information
  • Founded
  • GMRE 2011
  • MRVI 2014
  • Country
  • GMRE United States
  • MRVI United States
  • Employees
  • GMRE N/A
  • MRVI N/A
  • Industry
  • GMRE Real Estate Investment Trusts
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GMRE Real Estate
  • MRVI Health Care
  • Exchange
  • GMRE Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • GMRE 450.4M
  • MRVI 376.2M
  • IPO Year
  • GMRE N/A
  • MRVI 2020
  • Fundamental
  • Price
  • GMRE $30.86
  • MRVI $3.34
  • Analyst Decision
  • GMRE Buy
  • MRVI Hold
  • Analyst Count
  • GMRE 3
  • MRVI 9
  • Target Price
  • GMRE $51.88
  • MRVI $4.54
  • AVG Volume (30 Days)
  • GMRE 255.0K
  • MRVI 1.4M
  • Earning Date
  • GMRE 11-05-2025
  • MRVI 11-06-2025
  • Dividend Yield
  • GMRE 9.67%
  • MRVI N/A
  • EPS Growth
  • GMRE N/A
  • MRVI N/A
  • EPS
  • GMRE 0.34
  • MRVI N/A
  • Revenue
  • GMRE $141,896,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • GMRE $7.21
  • MRVI N/A
  • Revenue Next Year
  • GMRE $2.80
  • MRVI $7.23
  • P/E Ratio
  • GMRE $92.42
  • MRVI N/A
  • Revenue Growth
  • GMRE 2.95
  • MRVI N/A
  • 52 Week Low
  • GMRE $30.09
  • MRVI $1.67
  • 52 Week High
  • GMRE $48.13
  • MRVI $8.54
  • Technical
  • Relative Strength Index (RSI)
  • GMRE 73.17
  • MRVI 69.44
  • Support Level
  • GMRE $32.16
  • MRVI $2.94
  • Resistance Level
  • GMRE $33.48
  • MRVI $3.30
  • Average True Range (ATR)
  • GMRE 1.24
  • MRVI 0.20
  • MACD
  • GMRE 0.21
  • MRVI 0.04
  • Stochastic Oscillator
  • GMRE 72.65
  • MRVI 91.98

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: